The biomed company that made 180 kibbutzniks millionaires
Founded by an Arab Muslim, owned by a kibbutz, Enzymotec is a study in contrasts
Floated in late September on Nasdaq's Global Select Market at a value of $300 million, Enzymotec is an Israeli biomed success story with operations extending to the jungles of Brazil and the ice floes of the Arctic Circle.
register with haaretz
Like us on Facebook and get articles directly in your news feed